MarketCap
Facebook
X
TelegramAnnual report 2026
added 04-02-2026
IRIDEX Corporation Retained Earnings 2011-2026 | IRIX
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings IRIDEX Corporation
| 2026 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -92.4 M | -88 M | -79 M | -69.7 M | -56.9 M | - | -50.6 M | -41.8 M | -29 M | -4.41 M | -4.88 M | - | -14.9 M | -17.2 M | -21.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -4.41 M | -92.4 M | -43.9 M |
Quarterly Retained Earnings IRIDEX Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -92.3 M | -90.7 M | -89.7 M | -88 M | -87.1 M | -85.2 M | -82.5 M | -79 M | -76.1 M | -74.3 M | -71.6 M | -69.7 M | -68.6 M | -66.8 M | -64.6 M | -56.9 M | -59.7 M | -57.6 M | -59 M | - | -56.8 M | -55 M | -52.3 M | -50.6 M | -50.6 M | -50.6 M | -50.6 M | -41.8 M | -41.8 M | -41.8 M | -41.8 M | -29 M | -29 M | -29 M | -29 M | -16.1 M | -16.1 M | -16.1 M | -16.1 M | -4.88 M | -4.85 M | -5.29 M | -4.64 M | - | -13.6 M | -14.1 M | -14.4 M | -14.9 M | -14.9 M | -14.9 M | -14.9 M | -17.2 M | -17.2 M | -17.2 M | -17.2 M | -18.6 M | -18.6 M | -18.6 M | -18.6 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -4.64 M | -92.3 M | -42.1 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B |  USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 12.0 | -0.58 % | $ 1.62 B | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 9.15 | -2.51 % | $ 259 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 36.35 | -1.05 % | $ 5.42 K | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 15.71 | -1.44 % | $ 369 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-63.5 M | $ 3.4 | -1.73 % | $ 127 M |  France |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
2.48 B | $ 168.12 | -2.18 % | $ 12.6 B | USA |
 |
AxoGen
AXGN
|
-307 M | $ 31.05 | -4.87 % | $ 1.43 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
-802 M | $ 4.01 | -2.91 % | $ 849 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.61 | 3.37 % | $ 38 M | USA |
 |
TELA Bio
TELA
|
-398 M | $ 0.69 | 9.81 % | $ 32.4 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 9.65 | -0.52 % | $ 346 M | USA |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.58 | -0.11 % | $ 122 M | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
5.57 B | $ 61.35 | -1.93 % | $ 90.8 B | USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 11.1 | 1.19 % | $ 1.67 B | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 34.34 | 0.81 % | $ 1.07 B | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 90.53 | 2.15 % | $ 12.2 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 80.81 | -0.42 % | $ 47.3 B | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 1.76 | -7.37 % | $ 1.07 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
940 M | $ 9.31 | - | $ 717 M | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 54.8 | 1.25 % | $ 1.61 B | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 85.37 | -0.29 % | $ 2.97 B | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
LENSAR
LNSR
|
-178 M | $ 5.84 | -0.85 % | $ 69.8 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
Medtronic PLC
MDT
|
31.5 B | $ 86.48 | 0.22 % | $ 111 B | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
Myomo
MYO
|
-119 M | $ 0.67 | -4.29 % | $ 28 M | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |